Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
about
Signal transduction of platelet-induced liver regeneration and decrease of liver fibrosisLiver fibrosis: mechanisms of immune-mediated liver injuryHepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosisIs Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?Liver functions in silica-exposed workers in Egypt: possible role of matrix remodeling and immunological factorsIncreased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoLiver fibrosisHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseUsefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver diseaseProtective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in miceSelective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis CAn herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesisDownregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation-related protein (ADRP).Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism.Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis.Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.Altered circulating levels of matrix metalloproteinases and inhibitors associated with elevated type 2 cytokines in lymphatic filarial diseaseCellular fibronectin stimulates hepatocytes to produce factors that promote alcohol-induced liver injuryTumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosisGene expression profiling reveals underlying molecular mechanism of hepatoprotective effect of Phyllanthus niruri on thioacetamide-induced hepatotoxicity in Sprague Dawley ratsPlasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosisReactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells.Targeted recombinant fusion proteins of IFNγ and mimetic IFNγ with PDGFβR bicyclic peptide inhibits liver fibrogenesis in vivo.Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis.HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signalingPathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model.Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantationModulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells."Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells.Reversal of liver fibrosis and cirrhosis--an emerging reality.Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in ratsMatrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.
P2860
Q27011588-E37E437E-3949-49A9-A479-FAFEDE7D10C9Q27027766-AC2322DC-1717-42B6-A552-09B1BC7EF9A2Q27316480-8F60E0D4-4749-47A9-9899-4CE335C0C968Q27330629-C0D95E6F-DC90-4E4E-B3CB-AC2913EC3338Q28389870-BA0FD44E-0BF9-4811-AF6B-AE5BCA4F3DC5Q28584350-408CF4BD-80AD-42C9-B885-3F7DAF5EEB11Q29547449-C7E5C12D-FF88-492D-84D8-648F3CA8F6FFQ29616840-CEEA7C24-017F-4B6C-B5FB-C76F01ED1BDEQ30473375-B3111C0D-3C27-4752-A3A0-67BAC9298096Q33565557-E3A41D17-E0E7-4A55-987C-5B424B9345E9Q33594283-377ED3A6-1823-4045-8F50-A489B17F0BCAQ33622449-46940D8B-BFBB-4902-9478-5DBEC7BAD7D2Q33669920-960DFC5F-3334-47EE-BDE9-D13FAC0125A7Q33788611-1DBB1096-A520-48A4-A137-D7223E687941Q33868992-3669716B-7A58-40FE-AEFE-F589769C3646Q33886918-56EC1968-93CA-4FBB-BB75-8C6681DF1CB1Q34036116-5D3221A6-1FF3-4019-80F9-74E46A660D71Q34078665-8E1C8246-6190-47DE-A180-256AFDDA2A53Q34116253-BF166301-B3A6-44E0-91E8-7D33DB6E1BB6Q34284758-8EBA73DC-AE21-488A-86B6-48D2F04F1C5CQ34297175-C8BA5E09-A941-4FAD-B0BF-C102CBA61A64Q34695161-DA387857-00F7-4E69-AE17-B69143E5E781Q34766246-D4FB9BC9-957E-488C-A9C2-0D604613EE47Q34769928-00E51710-FE25-469D-ACF0-5244BB212B3EQ34800228-7C60BA80-6859-40E8-8854-D79BAD779277Q34984527-1C2F6C7B-F5FC-48EC-9F8A-E837435C5B1EQ35079242-0F898AA7-6D6B-44BA-A7FB-473FAA75A9A6Q35108259-821202A4-4BC1-4B5B-A0C7-BFB5FF610016Q35114053-4298576E-31FC-44BF-8879-ED99BB58F328Q35122931-17662F94-8B8A-4307-88CC-F7B4A5E88898Q35165971-6EDE7248-B541-42C2-97C9-56A98339193DQ35167030-9BE4B1CE-BA3B-4897-A8F9-C19563A7611DQ35168136-BB4FE327-3C06-4E4B-A622-22EF101A6B89Q35532301-9AAADD9E-F54F-44E1-81BD-08C11E17F4ADQ35575885-7809DB16-BCC3-49CD-9BEE-D2D0A6FDD7A3Q35649316-091D231B-143C-483B-B434-7A9AAF2111E2Q35687080-41907D5C-3038-4C28-8377-B88E43464347Q35760670-4A3ABFB5-CB4A-471C-9DAB-0C461F94A546Q35768956-66AC47EC-E044-49E2-B396-C5B22F733374Q35777649-364122DE-8A20-439B-8A94-5BDBB69055E1
P2860
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@ast
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@en
type
label
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@ast
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@en
prefLabel
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@ast
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@en
P1476
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
@en
P2093
P304
P356
10.1152/AJPGI.2000.279.2.G245
P577
2000-08-01T00:00:00Z